Invitrogen™ Human ELISA kit of amyloid precursor protein

Ref.: BL-RE-106061Manufacturer ref.: KHB0051 96 tests
€814.00 excl. VAT

L-ELISA of amyloid precursor protein (APP) quantifies human APA in human cerebrospinal fluid and human cell lysates. The dosage will only recognize the natural and recombinant human APP. Method principle...

Accession number
P05067
Dose range
0.78-50 ng/ml
Sensitivity of the dosage
<0,4 ng
Concentration
0.78 to 50 ng/ml
Conjugate
Biotin
Brand
Invitrogen

L-ELISA of amyloid precursor protein (APP) quantifies human APA in human cerebrospinal fluid and human cell lysates. The dosage will only recognize the natural and recombinant human APP. Method principle...

L-ELISA of amyloid precursor protein (APP) quantifies human APA in human cerebrospinal fluid and human cell lysates. The dosage will only recognize the natural and recombinant human APP. Principle of the L-ELISA solid phase sandwich method for human APP (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.

The amyloid precursor protein (APP) or beta amyloid protein works as a cell surface kinesin I membrane receptor, which induces the axonal transport of beta-secretase and presenin 1; the APP is rapidly internalized by clathrin-coated pits. L-APP plays a key role in neuritis growth, neuronal adhesion and l-axonogenesis. mutations in the APP gene can cause Alzheimer's disease 1 (MA1). This antibody recognizes the MW-aPA (b-APP770) of about 100 kDa. Order information

Shipping conditions: Wet ice

Measurement range

Dose range: 0.78-50 ng/ml.

Duration of dosing

Total duration of dosing: 4 hours.

Reproducibility

Coefficient of intra-dose variation 6.3%, inter-dose 7.4%.

Target

Target: Human.

Samples

Sample type: Cephalochidial fluid, Cell Lysates (cell Lysat volume, 10 μl; cerebral fluid, 10 μl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)10735773
Specifications
Accession numberP05067
Dose range0.78-50 ng/ml
Sensitivity of the dosage<0.4 ng
Concentration0.78 to 50 ng/ml
ConjugateBiotin
Product typeKit ELISA
Type of sampleCyphalorrhoidal liquid, Cell Lysates
Type of substrateProteins associated with amyloids
Target speciesHuman
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)351
Gene symbol(s)AAA,ABETA,ABPP,AD1I,CTFgamma,CVAP,PN-II,PN2,APP
Incubation time4 h
Coefficient of inter-dose variation7.4%
Coefficient of intra-dose variation6.3%
Contents of kits96-well pre-coated plate, Streptavidine HRP, HRP diluent, Wash pad, Chromogen, Stop solution, Adhesive plate covers
Marker or dyeHRP
Genetic markerEXPERT
Quantity96 tests
Regulatory statusRUO
TargetHuman
Test time1 h 20 min
Physical characteristics
Volume of sampleCell Lysat, 10 μl; cerebrospinal fluid, 10 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h

Origin and customs

Manufacturer ref.KHB0051
Country of originAutriche
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.